drugset
drugset / Trial / NCT03450759

A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects

NCT03450759 ↗

Phase 1 Completed 13 enrolled AstraZeneca Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will evaluate pharmacokinetics (PK) of four different formulations with different release profiles of AZD9977 (PART A) in the fasted state, and one of the formulation will be selected for further development (Part B). In Part B, the influence of food on the PK of AZD9977 will be evaluated

Timeline

Start
2018-03-28
Primary completion
2018-06-06
Completion
2018-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject balcinrenone Small molecule 195 mg Oral

Indications

No indication recorded.